Another incremental step forward in one of MindMed's leading psychedelics R&D initiatives.
More U.S. Military Funding For Psychedelic Drug R&D As PTSD Crisis Worsens
To commercialize psychedelic drugs, they first have to be legalized. In the United States, an important ally in this battle has surfaced: the DoD.
Mind Cure Announces Non-Brokered Private Placement of up to $3 Million
Mind Cure Health is seeking to raise $3 million via the sale of 6.66 million units.
Navy SEAL Foundation Contributes $50,000 to Support Major PTSD Study
The Navy SEAL Foundation (NSF) recently pledged one of the organization’s largest single grants in its 20-year history to support a major Post Traumatic Stress Disorder (PTSD) study.
A Market Reality Check For Psychedelic Stocks
The Psychedelics Revolution is here to stay. The solutions of tomorrow are the investments of today.
Mind Cure Announces Hiring of Award-Winning Experimental Scientist Dr. Ryan Hartwell as Chief Science Officer
Mind Cure's new Chief Science Officer (CSO) brings experience in drug research as well as natural product development.
COMPASS Pathways joins the Psychiatry Consortium in a collaboration to accelerate drug discovery in mental health care
Compass joins an international organization dedicated to advancing psychedelic drug research.
New Psychedelic Stocks: The Menu Is Getting Longer For Investors
Three new psychedelic stocks are trading publicly. One commenced trading last week, two more are coming this week.
Entheon Biomedical Corp. (formerly MPV Exploration Inc.) Announces Completion of Amalgamation and Final Approval from the Canadian Securities Exchange
Entheon Biomedical has announced that it expects to commence public trading on or about November 12th, symbol "ENBI".
Cybin Completes Reverse Take-Over Transaction
Cybin Corp has completed its RTO and received approval to commence trading on the NEO Exchange (symbol "CYBN") and expects to begin trading on or about November 10th.
Pure Extracts Technologies Corp. Commences Trading on the Canadian Securities Exchange (CSE)
Pure Extracts is now trading under the symbol "PULL".
Field Trip Health Ltd. Prepares to Enter Oregon Market following the Passage of Measure 109 in Oregon, Creating the First Legal Market for Psilocybin Services
Field Trip plans to enters Oregon's medicinal market for psilocybin-assisted psychotherapy.
